跳至主要内容
临床试验/NCT03085654
NCT03085654已完成早期 1 期

Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety

University of Electronic Science and Technology of China1 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2017年3月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
147
试验地点
1
主要终点
Changes between acute and chronic administration of oxytocin on amygdala connectivity as assessed by fMRI

研究概览

简要总结

To examine whether multiple doses of oxytocin have different effects on behavior and neural indices in males with high or low trait anxiety.

详细描述

In the present study, healthy male subjects' trait anxiety levels will be assessed by the sub-trait inventory of the State-Trait Anxiety Inventory (STAI). According to subjects' trait anxiety scores, they will be divided into high or low anxiety experimental groups.

Next, experiments will investigate the acute effect (single dose) and chronic effect (3 doses or 5 doses) of oxytocin on brain functional connectivity during resting-state and brain activation in response to watching emotional stimuli using functional magnetic resonance imaging (fMRI). Also the brain structure data (T1 and diffusion tensor imaging, DTI) of subjects will be collected. After finishing the scanning tasks, subjects will be required to rate the emotional valence, intensity and arousal of the pictures shown in the scanner.

During the course of the study subjects will complete a number of questionnaires: Empathy Quotient (EQ), Cheek and Buss Shyness scale (CBSS),Interpersonal Reactivity Index (IRI),Childhood Trauma Questionnaire (CTQ),Beck depression inventory (BDI), State-Trait Anxiety Inventory (STAI), Autism Spectrum Quotient (ASQ), Liebowitz Social Anxiety Scale (LSAS),Positive and Negative Affect Schedule (PANAS),d2 attention test, and the Visual Analogue Scale for anxiety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

High anxiety group (single dose)

Experimental

Oxytocin nasal spray or placebo nasal of one dose in subjects with high trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

High anxiety group (single dose)

Experimental

Oxytocin nasal spray or placebo nasal of one dose in subjects with high trait anxiety.

干预措施: Placebo nasal spray (Drug)

High anxiety group (3 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with high trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

High anxiety group (3 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with high trait anxiety.

干预措施: Placebo nasal spray (Drug)

High anxiety group (5 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray for 5 days,24 IU per day in subjects with high trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

High anxiety group (5 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray for 5 days,24 IU per day in subjects with high trait anxiety.

干预措施: Placebo nasal spray (Drug)

Low anxiety group (single dose)

Experimental

Oxytocin nasal spray or placebo nasal spray of one dose in subjects with low trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

Low anxiety group (single dose)

Experimental

Oxytocin nasal spray or placebo nasal spray of one dose in subjects with low trait anxiety.

干预措施: Placebo nasal spray (Drug)

Low anxiety group (3 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with low trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

Low anxiety group (3 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray interleaved during the 5 days( on the 1st,3rd and 5th day),24 IU per day in subjects with low trait anxiety.

干预措施: Placebo nasal spray (Drug)

Low anxiety group (5 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray for 5 days in subjects with low trait anxiety.

干预措施: Oxytocin nasal spray (Drug)

Low anxiety group (5 doses)

Experimental

Oxytocin nasal spray or placebo nasal spray for 5 days in subjects with low trait anxiety.

干预措施: Placebo nasal spray (Drug)

结局指标

主要结局

Changes between acute and chronic administration of oxytocin on amygdala connectivity as assessed by fMRI

时间窗: 5 days

Changes in neural connectivity between first dose and repeated dose will be assessed over the time course of 5 days

Changes between acute and chronic administration of oxytocin on amygdala activity as assessed by fMRI

时间窗: 5 days

Changes in neural activity between first dose and repeated dose will be assessed over the time course of 5 days

次要结局

  • Interaction of acute and chronic treatment effects with trait anxiety on neural activity(5 days)
  • Interaction of acute and chronic treatment effects with trait anxiety on neural connectivity(5 days)
  • Interaction of treatment effects on arousal ratings with trait anxiety (acute and changes with chronic treatment)(5 days)
  • Effects of oxytocin on arousal ratings of emotional stimuli (acute and changes with chronic treatment)(5 days)
  • Effects of oxytocin on valence ratings of emotional stimuli (acute and changes with chronic treatment)(5 days)
  • Interaction of treatment effects on valence ratings with trait anxiety (acute and changes with chronic treatment)(5 days)

研究者

发起方
University of Electronic Science and Technology of China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Keith Kendrick

Professor

University of Electronic Science and Technology of China

研究点 (1)

Loading locations...

相似试验

Multiple Dose Effect of Oxytocin on Males With High... | 临床试验